5933-28-8 Usage
General Description
5-Benzyloxyindole-3-acetamide is a chemical compound with the molecular formula C18H17N2O2. It is a derivative of indole-3-acetamide that has a benzyloxy group attached to the 5-position of the indole ring. 5-BENZYLOXYINDOLE-3-ACETAMIDE has potential applications in pharmaceutical research and drug development, particularly in the synthesis of new bioactive molecules and pharmaceutical agents. Its unique chemical structure and properties make it a promising candidate for further investigation in the development of new drugs for various medicinal purposes. Additionally, its benzyloxy group may confer specific biological activities or pharmacological properties that could be exploited in the development of novel therapeutics. Overall, 5-benzyloxyindole-3-acetamide is a compound of interest in the field of medicinal chemistry and pharmaceutical science.
Check Digit Verification of cas no
The CAS Registry Mumber 5933-28-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,9,3 and 3 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 5933-28:
(6*5)+(5*9)+(4*3)+(3*3)+(2*2)+(1*8)=108
108 % 10 = 8
So 5933-28-8 is a valid CAS Registry Number.
InChI:InChI=1/C17H16N2O2/c18-17(20)8-13-10-19-16-7-6-14(9-15(13)16)21-11-12-4-2-1-3-5-12/h1-7,9-10,19H,8,11H2,(H2,18,20)
5933-28-8Relevant articles and documents
Brain-specific drug delivery
-
, (2008/06/13)
The subject compounds, which are adapted for the site-specific/sustained delivery of centrally acting drug species to the brain, are: (a) compounds of the formula wherein [D] is a centrally acting drug species, and [DHC] is the reduced, biooxidizable, blood-brain barrier penetrating lipoidal form of a dihydropyridine pyridinium salt redox carrier, with the proviso that when [DHC] is STR1 wherein R is lower alkyl or benzyl and [D] is a drug species containing a single NH2 or OH functional group, the single OH group when present being a primary or secondary OH group, said drug species being linked directly through said NH2 or OH function group to the carbonyl function of [DHC], then [D] must be other than a sympathetic stimulant, steroid sex hormone or long chain alkanol; and (b) non-toxic pharmaceutically acceptable salts of compounds of formula (I) wherein [D] is a centrally acting drug species and [DHC] is the reduced, biooxidizable, blood-brain barrier penetrating lipoidal form of a dihydropyridine pyridinium salt redox carrier. The corresponding ionic pyridinium salt type drug/carrier entitles [D--QC]+ X- are also disclosed.
